Drug Therapy for Generalized Anxiety Disorder Among the Elderly
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This study will determine the efficacy of escitalopram (Lexapro®), an anti-anxiety drug, for
generalized anxiety disorder (GAD) and the ways genetics affect response to treatment for GAD
in elderly individuals.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute of Mental Health (NIMH) University of Pittsburgh